๐ฌ ๐ง๐ผ๐ฝ ๐๐๐ ๐ข๐ ๐ถ๐ป ๐๐๐ฟ๐ผ๐ฝ๐ฒ ๐ฎ๐ฌ๐ฎ๐ฐ! ๐ Whether you are a small molecule, biologics or CGT CDMO, the global market for is forecast to keep expanding. The European CDMO market is projected to grow at a CAGR of 5% to 7.4% according to various reports. Some of my personal favourites (in no particular order ๐ ) include : Axplora Corden Pharma - A Full-Service CDMO UQUIFA, MINAKEM 3P Biopharmaceuticals Bachem Piramal Pharma Ltd Exothera SK pharmteco Celonic Group FUJIFILM Diosynth Biotechnologies Ascend Advanced Therapies ๐๐ค๐ฉ๐: ๐ฟ๐ช๐ ๐ฉ๐ค ๐ฉ๐๐ ๐๐๐๐ ๐ฃ๐ช๐ข๐๐๐ง ๐ค๐ ๐๐ข๐๐ก๐ก ๐๐ค๐ก๐๐๐ช๐ก๐ ๐ข๐๐ฃ๐ช๐๐๐๐ฉ๐ช๐ง๐๐ง๐จ ๐๐ฃ ๐๐ช๐ง๐ค๐ฅ๐, ๐ฉ๐๐๐ฎ ๐๐๐ซ๐ ๐ค๐ฃ๐ก๐ฎ ๐๐ฃ๐๐ก๐ช๐๐๐ ๐พ๐ฟ๐๐๐จ ๐ฌ๐๐ฉ๐ ๐ข๐ค๐ง๐ ๐ฉ๐๐๐ฃ ๐ค๐ฃ๐ ๐๐๐๐๐ก๐๐ฉ๐ฎ. Anyone to add to the list?? Comment below๐ Source: PharmaSource 1. Download the latest hi-res infographic here: https://lnkd.in/gNxpEmbx 2. Add your company here if it's missing: https://lnkd.in/gSweD5fX #CDMO #SmallMolecules #Biologics #CGT
GTP Bioways is missing in the biologics section ๐ข
In the section "small molecules" we miss ChemCon GmbH. It would be great join this club.
Jakub Knurek
2w
I tell you that you are Mabion S.A., and on this rock you could build your biologics, and the gates of EMA/FDA will not overcome it.
Merck Life Science is definitely expanding its multi-modality CDMO footprint in Europe and North America, with sites in Germany (small molecules, mRNA), Switzerland (small molecules), France (Biologics), and USA (VV, small molecules, HPAPI, ADCs and bioconjugates, mRNA LNPs). Worth a mention ๐
BSP Pharmaceuticals is missing in the list as well! We are a european CDMO focused on innovative products for oncology, immuno-oncology, CNS and other relevant therapeutic indications. We serve innovators for both small molecules and biologics and currently we are one of the leader in the bioconjugates space offering integrated service for Drug substance and Drug Product under the same roof. Learn more on our web site: https://www.bsppharmaceuticals.com/!
Thanks for sharing. Cellex is missing as a leading Cell Therapy CDMO. We have actually manufactured 1000 cellular products in the first six month of 2024 ๐ช
Ferenc Bรณdi
2w
Egis Pharmaceuticals PLC should be on the list as a European C(D)MO at Small Molecules. See the details at: https://int.egis.health/egis-pharma-services-en It would be great to join.
Li Miao
2w
Several updates/corrections: 3P and Biovian merged last year into 3PBiovian, so letโs do not double-count them; Wuxiโs CGT CDMO business is under the name of Wuxi ATU (Advanced Therapy Unit), instead of Wuxi Biologics as listed in the chartโฆ also, IDT Biologika was recently acquired 60% by SK bioscience. Otherwise, a good list for reference!
Senior Director Business Development at Icosagen Cell Factory
2wIcosagen as European mammalian protein CRDMO should be on the list, Harriet, combining pre-clinical CRO and clinical CDMO capabilities, from mAb discovery, transient R&D mgs / grams, protein engineering, to stable cell line development and 50/200/1000L clinical GMP kilograms. 25 year, fully independent family business with some 180 scientists, and Estonia's Company and Innovator of the Year 2023.